Hello, dear readers! Welcome to our monthly letters column. We are in the heart of allergy season, which means some of us are ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...

Highest-risk classification: FDA labeled Boston Scientific’s pacemaker recall as Class I, the most serious, due to potential ...

“Defibrillation testing can be safely omitted after S-ICD implantation when guided by the PRAETORIAN score,” Knops concluded, ...

A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...

Background Persistent shockable rhythms (refractory to or recurring after three or more defibrillation attempts) are ...

A dedicated bipolar implantable cardioverter-defibrillator (ICD) lead for conduction system pacing (CSP) performed well in a ...

The PRAETORIAN-DFT randomized trial found that omitting defibrillation testing during subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation, when guided by the PRAETORIAN score, did ...

The Department for Work and Pensions has confirmed a list of 537 conditions that qualifies for up to £779 a May. As of April ...

Nevertheless, despite the recommendations to not routinely consider advanced age as one of the most important risk factors for periprocedural complications of transvenous lead extraction (TLE), ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging geography in the heart, for delivering electric signals that more closely ...